Statements of Operations (USD $)	3 Months Ended
	Mar. 31, 2012	Mar. 31, 2011
Revenues:
Product sales	$ 240	$ 2,720
Total revenues	240	2,720
Cost of revenues:
Product sales	96	1,431
Total cost of revenues	96	1,431
Gross margin	144	1,289
Operating expenses:
Research and development expenses	84,189	86,945
Selling, general and administrative expenses	73,998	111,224
Total operating expenses	158,187	198,169
Operating loss	(158,043)	(196,880)
Other income (expense):
Gain on debt conversion	15,220
Change in fair value of derivatives	(23,631)	(610)
Interest expense	(69,660)	(23,063)
Other income		300
Net loss	(236,114)	(220,253)
Preferred stock dividend	(6,558)	(4,206)
Net loss applicable to common shareholders	$ (242,672)	$ (224,459)
Basic and diluted net loss per average share available to common shareholders (in Dollars per share)	$ 0.00	$ 0.00
Weighted average common shares outstanding – basic and diluted (in Shares)	72,802,438	61,172,113